期刊文献+
共找到4篇文章
< 1 >
每页显示 20 50 100
Current status of imaging in nonalcoholic fatty liver disease 被引量:11
1
作者 Qian Li Manish Dhyani +2 位作者 Joseph R Grajo Claude Sirlin Anthony E Samir 《World Journal of Hepatology》 CAS 2018年第8期530-542,共13页
Non-alcoholic fatty liver disease(NAFLD) is the most common diffuse liver disease, with a worldwide prevalence of 20% to 46%. NAFLD can be subdivided into simple steatosis and nonalcoholic steatohepatitis. Most cases ... Non-alcoholic fatty liver disease(NAFLD) is the most common diffuse liver disease, with a worldwide prevalence of 20% to 46%. NAFLD can be subdivided into simple steatosis and nonalcoholic steatohepatitis. Most cases of simple steatosis are non-progressive, whereas nonalcoholic steatohepatitis may result in chronic liver injury and progressive fibrosis in a significant minority. Effective risk stratification and management of NAFLD requires evaluation of hepatic parenchymal fat, fibrosis, and inflammation. Liver biopsy remains the current gold standard; however, non-invasive imaging methods are rapidly evolving and may replace biopsy in some circumstances. These methods include well-established techniques, such as conventional ultrasonography, computed tomography, and magnetic resonance imaging and newer imaging technologies, such as ultrasound elastography, quantitative ultrasound techniques, magnetic resonance elastography, and magnetic resonancebased fat quantitation techniques. The aim of this article is to review the current status of imaging methods for NAFLD risk stratification and management, including their diagnostic accuracy, limitations, and practical applicability. 展开更多
关键词 simple STEATOSIS non-alcoholic fatty liver disease Ultrasonography Computed tomography NONALCOHOLIC STEATOHEPATITIS ELASTOGRAPHY Magnetic resonance
下载PDF
脂肪衰减参数在不同中医证型脂肪肝诊断中的应用 被引量:13
2
作者 张婷 董淑娟 韩艳俊 《河南中医》 2016年第11期1940-1942,共3页
目的:探讨瞬时弹性成像技术脂肪衰减参数(FAI值)在不同中医证型脂肪肝诊断中的应用。方法:选取本院治疗的非酒精性单纯性脂肪肝患者148例和健康对照组144例。使用Fibro Touch检测非酒精性单纯性脂肪肝患者和健康对照组的FAI值,按照2011... 目的:探讨瞬时弹性成像技术脂肪衰减参数(FAI值)在不同中医证型脂肪肝诊断中的应用。方法:选取本院治疗的非酒精性单纯性脂肪肝患者148例和健康对照组144例。使用Fibro Touch检测非酒精性单纯性脂肪肝患者和健康对照组的FAI值,按照2011年制定的《非酒精性脂肪性肝病中西医诊疗共识意见》对非酒精性单纯性脂肪肝患者进行中医辨证分型,并用彩色多普勒超声诊断仪进行脂肪肝超声分级。结果:对非酒精性单纯性脂肪肝患者与健康人的FAI值进行比较,发现患者的FAI值明显高于健康人(t=37.414,P=0.000),表明FAI值可用于定量检测非酒精性单纯性脂肪肝;比较不同分级中医证型非酒精性单纯性脂肪肝患者的FAI值,发现不同中医证型FAI值各不相同(F=3.15,P<0.05),且重度痰瘀互结证患者的FAI值明显高于中度和轻度(P<0.05),中度患者显著高于轻度(P<0.05),表明FAI值可用于诊断脂肪肝的病变程度;对FAI值与非酒精性单纯性脂肪肝分级进行相关性分析,发现FAI值和脂肪肝程度呈正相关(r=0.758,P=0.000),随着脂肪肝程度的加重,FAI值随之升高;采用ROC曲线分析,FAI值诊断轻度脂肪肝ROC曲线下面积为0.807、中度脂肪肝ROC曲线下面积为0.979,表明FAI值对非酒精性单纯性脂肪肝的检测准确率高。结论:瞬时弹性成像技术脂肪衰减参数可定量、准确诊断非酒精性单纯性脂肪肝。 展开更多
关键词 非酒精性单纯性脂肪肝 脂肪衰减参数 肝郁气滞证 肝郁脾虚证 痰湿内阻证 湿热蕴结证 痰瘀互结证
下载PDF
Translational research and innovation in modern transplant practice:Paradigms from Greece and around the world
3
作者 Georgios Tsoulfas Ioannis Boletis Vassilios Papalois 《World Journal of Transplantation》 2023年第2期25-27,共3页
The continuous clinical and technological advances,together with the social,health and economic challenges that the global population faces,have created an environment where the evolution of the field of transplantati... The continuous clinical and technological advances,together with the social,health and economic challenges that the global population faces,have created an environment where the evolution of the field of transplantation is essentially necessary.The goal of this special issue is to provide a picture of the current status of transplantation in Greece as well as in many other countries in Europe and around the world.Authors from Greece and several other countries provide us with valuable insight into their respective areas of transplant expertise,with a main focus on the field of translational research and innovation.The papers that are part of this Special Issue“Translational Research and Innovation and the current status of Transplantation in Greece”have presented innovative and meaningful approaches in modern transplant research and practice.They provide us with a clear overview of the current landscape in transplantation,including liver transplantation in the context of a major pandemic,the evolution of living donor kidney transplantation or the evolution of the effect of hepatitis C virus infection in transplantation,while at the same time explore more recent challenges,such as the issue of frailty in the transplant candidate and the changes brought by newer treatments,such as immunotherapy,in transplant oncology.Additionally,they offer us a glimpse of the effect that technological innovations,such as virtual reality,can have on transplantation,both in terms of clinical and educational aspects.Just as critical is the fact that this Special Issue emphasizes the multidisciplinary,collaborative efforts currently taking place that link transplant research and innovation with other cutting-edge disciplines such as bioengineering,advanced information technology and artificial intelligence.In this Special Issue,in addition to the clinical and research evolution of the field of transplantation,we are witnessing the importance of interdisciplinary collaboration in medicine. 展开更多
关键词 Translational research non-alcoholic fatty liver disease IMMUNOTHERAPY PANDEMIC liver transplantation BIOENGINEERING Artificial intelligence IMMUNOSUPPRESSION Transplant oncology Living donor kidney transplantation
下载PDF
逍遥理气方治疗非酒精性单纯性脂肪肝(肝脾气滞证)证侯疗效分析 被引量:1
4
作者 崔翔 王新磊 +2 位作者 华鹏 赵军 王振东 《中国中西医结合消化杂志》 CAS 2016年第9期681-683,共3页
[目的]观察逍遥理气方对肝脾气滞证非酒精性单纯性脂肪肝(NAFL)的证候疗效。[方法]采用随机对照方法,70例肝脾气滞证NAFL患者分为治疗组(n=36例)和对照组(n=34例),在一般干预的基础上,治疗组采用逍遥理气方内服,对照组采用水飞蓟宾胶囊... [目的]观察逍遥理气方对肝脾气滞证非酒精性单纯性脂肪肝(NAFL)的证候疗效。[方法]采用随机对照方法,70例肝脾气滞证NAFL患者分为治疗组(n=36例)和对照组(n=34例),在一般干预的基础上,治疗组采用逍遥理气方内服,对照组采用水飞蓟宾胶囊口服,治疗6周后,采用中医证候疗效和慢性肝病问卷(CLDQ)评价疗效。[结果]1治疗6周后,治疗组证候总有效率为88.9%,对照组为70.1%,2组比较差异有统计学意义(P<0.05)。2治疗组胁胀、胸腹满闷症状评分较治疗前均明显降低(P<0.01),与对照组治疗后比较有统计学意义(P<0.05)。3在CLDQ积分方面,治疗组显著高于治疗前,差异有统计学意义(P<0.05)。[结论]逍遥理气方可有效改善肝脾气滞证NAFL证候,并能提高患者生存质量。 展开更多
关键词 逍遥理气方 非酒精性单纯性脂肪肝 肝脾气滞
原文传递
上一页 1 下一页 到第
使用帮助 返回顶部